{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:00:22Z","timestamp":1790949622928,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Med. Toxicol."],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s13181-026-01156-2","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T18:06:32Z","timestamp":1788372392000},"page":"415-422","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Octreotide Administration Methods in Sulfonylurea Poisoning: A Retrospective Chart Review"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-3438-4933","authenticated-orcid":false,"given":"Mayank","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kuai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"McElroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"issue":"3","key":"1156_CR1","doi-asserted-by":"publisher","first-page":"334","DOI":"10.7326\/0003-4819-108-3-334","volume":"108","author":"DM Nathan","year":"1988","unstructured":"Nathan DM, Roussell A, Godine JE. Glyburide or insulin for metabolic control in non-insulin-dependent diabetes mellitus. A randomized, double-blind study. Ann Intern Med. 1988;108(3):334\u201340. https:\/\/doi.org\/10.7326\/0003-4819-108-3-334.","journal-title":"Ann Intern Med"},{"issue":"1","key":"1156_CR2","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1067\/mem.2001.114314","volume":"38","author":"RA Harrigan","year":"2001","unstructured":"Harrigan RA, Nathan MS, Beattie P. Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity, and treatment. Ann Emerg Med. 2001;38(1):68\u201378. https:\/\/doi.org\/10.1067\/mem.2001.114314.","journal-title":"Ann Emerg Med"},{"issue":"1","key":"1156_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/0014-5793(85)80418-X","volume":"190","author":"H Abrahamsson","year":"1985","unstructured":"Abrahamsson H, Berggren P-O, Rorsman P. Direct measurements of increased free cytoplasmic Ca2+ in mouse pancreatic \u03b2-cells following stimulation by hypoglycemie sulfonylureas. FEBS Lett. 1985;190(1):21\u20134. https:\/\/doi.org\/10.1016\/0014-5793(85)80418-X.","journal-title":"FEBS Lett"},{"key":"1156_CR4","unstructured":"Bosse GM. Antidiabetics and Hypoglycemics\/Antiglycemics. In: Nelson LS, Howland MA, Lewin NA, Smith SW, Goldfrank LR, Hoffman RS, editors. Goldfrank\u2019s Toxicologic Emergencies, 11e. New York, NY: McGraw-Hill Education; 2019."},{"issue":"3","key":"1156_CR5","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3109\/15563659609013787","volume":"34","author":"DA Quadrani","year":"1996","unstructured":"Quadrani DA, Spiller HA, Widder P. Five year retrospective evaluation of sulfonylurea ingestion in children. J Toxicol Clin Toxicol. 1996;34(3):267\u201370. https:\/\/doi.org\/10.3109\/15563659609013787.","journal-title":"J Toxicol Clin Toxicol"},{"issue":"1","key":"1156_CR6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0022-3476(97)70138-0","volume":"131","author":"HA Spiller","year":"1997","unstructured":"Spiller HA, Villalobos D, Krenzelok EP, Anderson BD, Gorman SE, Rose SR, et al. Prospective multicenter study of sulfonylurea ingestion in children. J Pediatr. 1997;131(1):141\u20136. https:\/\/doi.org\/10.1016\/S0022-3476(97)70138-0.","journal-title":"J Pediatr"},{"issue":"6","key":"1156_CR7","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/S0196-0644(98)70240-9","volume":"31","author":"CS Szlatenyi","year":"1998","unstructured":"Szlatenyi CS, Capes KF, Wang RY. Delayed hypoglycemia in a child after ingestion of a single glipizide tablet. Ann Emerg Med. 1998;31(6):773\u20136. https:\/\/doi.org\/10.1016\/S0196-0644(98)70240-9.","journal-title":"Ann Emerg Med"},{"issue":"2","key":"1156_CR8","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/x00431-001-0862-z","volume":"161","author":"K Hussain","year":"2002","unstructured":"Hussain K, Mundy H, Aynsley-Green A, Champion M. A child presenting with disordered consciousness, hallucinations, screaming episodes and abdominal pain. Eur J Pediatr. 2002;161(2):127\u20139. https:\/\/doi.org\/10.1007\/x00431-001-0862-z.","journal-title":"Eur J Pediatr"},{"issue":"3","key":"1156_CR9","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jemermed.2004.09.012","volume":"28","author":"GL Little","year":"2005","unstructured":"Little GL, Boniface KS. Are one or two dangerous? Sulfonylurea exposure in toddlers. J Emerg Med. 2005;28(3):305\u201310. https:\/\/doi.org\/10.1016\/j.jemermed.2004.09.012.","journal-title":"J Emerg Med"},{"issue":"2","key":"1156_CR10","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/FTD.0b013e318197b7d7","volume":"31","author":"M Glatstein","year":"2009","unstructured":"Glatstein M, Garcia-Bournissen F, Scolnik D, Koren G, Finkelstein Y. Hypoglycemia in a healthy toddler. Ther Drug Monit. 2009;31(2):173\u20137. https:\/\/doi.org\/10.1097\/FTD.0b013e318197b7d7.","journal-title":"Ther Drug Monit"},{"issue":"1","key":"1156_CR11","first-page":"e51","volume":"17","author":"M Glatstein","year":"2010","unstructured":"Glatstein M, Garcia-Bournissen F, Scolnik D, Koren G. Sulfonylurea intoxication at a tertiary care paediatric hospital. Can J Clin Pharmacol. 2010;17(1):e51-6.","journal-title":"Can J Clin Pharmacol"},{"issue":"12","key":"1156_CR12","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1080\/15563650.2021.1989785","volume":"59","author":"DD Gummin","year":"2020","unstructured":"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, et al. 2020 annual report of the American Association of Poison Control Centers\u2019 National Poison Data System (NPDS): 38th annual report. Clin Toxicol. 2020;59(12):1282\u2013501. https:\/\/doi.org\/10.1080\/15563650.2021.1989785.","journal-title":"Clin Toxicol"},{"issue":"9","key":"1156_CR13","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1001\/archinte.1991.00400090133023","volume":"151","author":"W Palatnick","year":"1991","unstructured":"Palatnick W, Meatherall RC, Tenenbein M. Clinical spectrum of sulfonylurea overdose and experience with diazoxide therapy. Arch Internal Med 1960. 1991;151(9):1859\u201362. https:\/\/doi.org\/10.1001\/archinte.1991.00400090133023.","journal-title":"Arch Internal Med 1960"},{"issue":"1","key":"1156_CR14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0735-6757(96)90029-7","volume":"14","author":"ME Thoma","year":"1996","unstructured":"Thoma ME, Glauser J, Genuth S. Persistent hypoglycemia and hyperinsulinemia: caution in using glucagon. Am J Emerg Med. 1996;14(1):99\u2013101. https:\/\/doi.org\/10.1016\/S0735-6757(96)90029-7.","journal-title":"Am J Emerg Med"},{"issue":"10","key":"1156_CR15","doi-asserted-by":"publisher","first-page":"931","DOI":"10.2337\/diab.26.10.931","volume":"26","author":"N Altszuler","year":"1977","unstructured":"Altszuler N, Hampshire J, Moraru E. On the mechanism of diazoxide-induced hyperglycemia. Diabetes. 1977;26(10):931\u20135. https:\/\/doi.org\/10.2337\/diab.26.10.931.","journal-title":"Diabetes"},{"issue":"2","key":"1156_CR16","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s13181-010-0064-z","volume":"6","author":"PP Dougherty","year":"2010","unstructured":"Dougherty PP, Klein-Schwartz W. Octreotide\u2019s role in the management of sulfonylurea-induced hypoglycemia. J Med Toxicol. 2010;6(2):199\u2013206. https:\/\/doi.org\/10.1007\/s13181-010-0064-z.","journal-title":"J Med Toxicol"},{"issue":"9","key":"1156_CR17","doi-asserted-by":"publisher","first-page":"795","DOI":"10.3109\/15563650.2012.734626","volume":"50","author":"M Glatstein","year":"2012","unstructured":"Glatstein M, Scolnik D, Bentur Y. Octreotide for the treatment of sulfonylurea poisoning. Clin Toxicol (Phila). 2012;50(9):795\u2013804. https:\/\/doi.org\/10.3109\/15563650.2012.734626.","journal-title":"Clin Toxicol (Phila)"},{"issue":"1","key":"1156_CR18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1124\/pr.55.1.7","volume":"55","author":"ME Doyle","year":"2003","unstructured":"Doyle ME, Egan JM. Pharmacological agents that directly modulate insulin secretion. Pharmacol Rev. 2003;55(1):105\u201331. https:\/\/doi.org\/10.1124\/pr.55.1.7.","journal-title":"Pharmacol Rev"},{"issue":"3","key":"1156_CR19","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1210\/jcem.76.3.8445035","volume":"76","author":"PJ Boyle","year":"1993","unstructured":"Boyle PJ, Justice K, Krentz AJ, Nagy RJ, Schade DS. Octreotide reverses hyperinsulinemia and prevents hypoglycemia induced by sulfonylurea overdoses. J Clin Endocrinol Metab. 1993;76(3):752\u20136. https:\/\/doi.org\/10.1210\/jcem.76.3.8445035.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1156_CR20","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/pec.0b013e31828503cf","volume":"29","author":"PP Dougherty","year":"2013","unstructured":"Dougherty PP, Lee SC, Lung D, Klein-Schwartz W. Evaluation of the use and safety of octreotide as antidotal therapy for sulfonylurea overdose in children. Pediatr Emerg Care. 2013;29(3):292\u20135. https:\/\/doi.org\/10.1097\/pec.0b013e31828503cf.","journal-title":"Pediatr Emerg Care"},{"issue":"6","key":"1156_CR21","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1186\/cc3807","volume":"9","author":"PER Lheureux","year":"2005","unstructured":"Lheureux PER, Zahir S, Penaloza A, Gris M. Bench-to-bedside review: Antidotal treatment of sulfonylurea-induced hypoglycaemia with octreotide. Critical Care (London, England). 2005;9(6):543\u20139. https:\/\/doi.org\/10.1186\/cc3807.","journal-title":"Critical Care (London, England)."},{"issue":"sup119","key":"1156_CR22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3109\/00365528609087433","volume":"21","author":"K Kutz","year":"1986","unstructured":"Kutz K, N\u00fcesch E, Rosenthaler J. Pharmacokinetics of SMS 201-995 in healthy subjects. Scand J Gastroenterol. 1986;21(sup119):65\u201372. https:\/\/doi.org\/10.3109\/00365528609087433.","journal-title":"Scand J Gastroenterol"},{"issue":"5","key":"1156_CR23","doi-asserted-by":"publisher","first-page":"375","DOI":"10.2165\/00003088-199325050-00004","volume":"25","author":"P Chanson","year":"1993","unstructured":"Chanson P, Timsit J, Harris AG. Clinical pharmacokinetics of octreotide: therapeutic applications in patients with pituitary tumours. Clin Pharmacokinet. 1993;25(5):375\u201391. https:\/\/doi.org\/10.2165\/00003088-199325050-00004.","journal-title":"Clin Pharmacokinet"},{"key":"1156_CR24","unstructured":"Smith SW, Howland MA. Octreotide. In: Nelson LS, Howland MA, Lewin NA, Smith SW, Goldfrank LR, Hoffman RS, editors. Goldfrank\u2019s Toxicologic Emergencies, 11e. New York, NY: McGraw-Hill Education; 2019."},{"issue":"10","key":"1156_CR25","doi-asserted-by":"publisher","first-page":"540","DOI":"10.5694\/j.1326-5377.2004.tb06064.x","volume":"180","author":"BAL Crawford","year":"2004","unstructured":"Crawford BAL, Perera C. Octreotide treatment for sulfonylurea-induced hypoglycaemia. Med J Aust. 2004;180(10):540\u20131. https:\/\/doi.org\/10.5694\/j.1326-5377.2004.tb06064.x.","journal-title":"Med J Aust"},{"issue":"6","key":"1156_CR26","doi-asserted-by":"publisher","first-page":"e209","DOI":"10.1016\/j.jemermed.2013.05.016","volume":"45","author":"R Llamado","year":"2013","unstructured":"Llamado R, Czaja A, Stence N, Davidson J. Continuous octreotide infusion for sulfonylurea-induced hypoglycemia in a toddler. J Emerg Med. 2013;45(6):e209\u201313. https:\/\/doi.org\/10.1016\/j.jemermed.2013.05.016.","journal-title":"J Emerg Med"},{"issue":"6","key":"1156_CR27","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/j.1440-1754.2008.01339.x","volume":"44","author":"S Rath","year":"2008","unstructured":"Rath S, Bar\u2010Zeev N, Anderson K, Fahy R, Roseby R. Octreotide in children with hypoglycaemia due to sulfonylurea ingestion. J Paediatr Child Health. 2008;44(6):383\u20134. https:\/\/doi.org\/10.1111\/j.1440-1754.2008.01339.x.","journal-title":"J Paediatr Child Health"},{"issue":"7","key":"1156_CR28","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1136\/emj.2006.034868","volume":"23","author":"J Soderstrom","year":"2006","unstructured":"Soderstrom J, Murray L, Daly FFS, Little M. Toxicology case of the month: oral hypoglycaemic overdose. Emerg Med J. 2006;23(7):565\u20137. https:\/\/doi.org\/10.1136\/emj.2006.034868.","journal-title":"Emerg Med J"},{"issue":"3","key":"1156_CR29","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/00006565-199906000-00015","volume":"15","author":"HA Spiller","year":"1999","unstructured":"Spiller HA. Management of sulfonylurea ingestions. Pediatr Emerg Care. 1999;15(3):227\u201330. https:\/\/doi.org\/10.1097\/00006565-199906000-00015.","journal-title":"Pediatr Emerg Care"}],"container-title":["Journal of Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-026-01156-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13181-026-01156-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-026-01156-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:37:53Z","timestamp":1790948273000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13181-026-01156-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["1156"],"URL":"https:\/\/doi.org\/10.1007\/s13181-026-01156-2","relation":{},"ISSN":["1556-9039","1937-6995"],"issn-type":[{"value":"1556-9039","type":"print"},{"value":"1937-6995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]},"assertion":[{"value":"10 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Mayank Gupta, David Kuai, Nicole McElroy, and Joseph Carpenter declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflicts of Interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}